study for the comparison of usefulness, side effects, cost and quality of life of patient with high blood pressure after treatment with azilsartan versus telmisartan.
Not Applicable
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2019/08/020786
- Lead Sponsor
- Department of Pharmacology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. New patients with hypertension i.e not on any antihypertensive therapy.
2. Adult males and females of age 21 years or more.
Exclusion Criteria
1. Patients already on anti-hypertensives.
2. Patients with hypersensitivity to AZL or telmisartan.
3. Pregnant/ lactating women/ women planning to conceive.
4. Evidence of severe renal disorder.
5. Patients with hepatic insufficiencies.
6. Patients unwilling or unable to comply with the study proceedings.
7. Patients with severe bradycardia, cardiogenic shock, heart block, sick sinus syndrome, decompensated heart failure, bronchial asthma, hypothyroidism, CVA, CAD.
8. Patients with other co morbidities like hyperthyroidism, anxiety disorders.
9. Patients with refractory hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in blood pressure of patients of hypertension on azilsartan versus telmisartanTimepoint: baseline, 4week and 8weeks
- Secondary Outcome Measures
Name Time Method to monitor the side effects of both azilsartan and telmisartan in hypertensive patientsTimepoint: 6weeks